Cephalon Bid For Apotex Docs Denied In Provigil Suit

Law360, New York (March 4, 2011, 7:54 PM EST) -- A Pennsylvania federal judge ruled Friday that Cephalon Inc. was not entitled to data on Apotex Inc.'s manufacturing practices in an antitrust suit accusing Cephalon of conspiring to keep generic versions of its narcolepsy drug Provigil off the market.

Judge Mitchell S. Goldberg of the U.S. District Court for the Eastern District of Pennsylvania ruled Cephalon's argument that it was entitled to the documents "is based on a litany of 'what-ifs,' hypotheticals, assumptions and speculation related to the past, present and future business of Apotex."...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

APOTEX, INC. v. CEPHALON, INC. et al


Case Number

2:06-cv-02768

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Judge

MITCHELL S. GOLDBERG

Date Filed

June 26, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.